Intellia Therapeutics, Inc. (LON: 0JBU)
London
· Delayed Price · Currency is GBP · Price in USD
10.26
-0.26 (-2.43%)
At close: Jan 31, 2025
Intellia Therapeutics Employees
Intellia Therapeutics had 526 employees as of December 31, 2023. The number of employees decreased by 72 or -12.04% compared to the previous year.
Employees
526
Change (1Y)
-72
Growth (1Y)
-12.04%
Revenue / Employee
61.11K GBP
Profits / Employee
-740.83K GBP
Market Cap
845.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Intellia Therapeutics News
- 9 days ago - Did Intellia Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - NTLA - Accesswire
- 9 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Intellia Therapeutics, Inc - NTLA - Accesswire
- 9 days ago - Intellia Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Intellia Therapeutics, Inc. (NTLA) - Accesswire
- 9 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Intellia Therapeutics, Inc. (NTLA) And Encourages Shareholders to Connect - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Intellia Therapeutics, Inc. (NTLA) And Encourages Investors to Connect - Accesswire
- 11 days ago - Lost Money on Intellia Therapeutics, Inc. (NTLA)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - Accesswire
- 11 days ago - NTLA ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Intellia Therapeutics, Inc. Shareholders Who Lost Money - Accesswire
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Intellia Therapeutics, Inc. (NTLA) Stockholders to Inquire about Securities Investigation - Accesswire